Lymphoproliferative syndrome in an infant after stem cell transplantation: successful therapy with T-lymphocytes and anti-CD20 monoclonal antibodies

Med Pediatr Oncol. 2000 Nov;35(5):503-5. doi: 10.1002/1096-911x(20001101)35:5<503::aid-mpo12>3.0.co;2-d.

Authors

D K Stachel¹, I Schmid, F Schuster, M Stehr, F A Baumeister, J Müller-Höcker

Affiliation

¹ Department of Hematology-Oncology, Children's Hospital of the University of Munich, Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany. Daniel.Stachel@kk-i.med.uni-muenchen.de

PMID: 11070486
DOI: 10.1002/1096-911x(20001101)35:5<503::aid-mpo12>3.0.co;2-d

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use
Epstein-Barr Virus Infections / etiology
Epstein-Barr Virus Infections / immunology
Epstein-Barr Virus Infections / therapy*
Female
Hematopoietic Stem Cell Transplantation*
Humans
Immunotherapy, Adoptive / methods*
Infant
Lymphoproliferative Disorders / immunology
Lymphoproliferative Disorders / therapy*
Lymphoproliferative Disorders / virology
T-Lymphocytes / immunology

Substances

Antibodies, Monoclonal